Global Liquid Biopsy Market: Analysis By Biomarkers (C-Tumor Cells, C-Tumor DNA, Vesicles), Cancer Type, By Product (Instruments, Reagents), By Region, By Country (2019 Edition): Opportunities and Forecast (2017-2024)
Executive Summary
According to Azoth Analytics research report, the Liquid Biopsy was valued at USD 899.55 million for the year 2018.
Over the recent years, Liquid Biopsy has been witnessing considerable growth on the back of growing focus on immunotherapy to cure cancer and shifting trend towards precision medicine along with high per capita healthcare expenditure and rapid adoption of novel diagnostic test by oncologist. Further, rising awareness for the early detection of cancer and sharp rise in its incidences have contributed to the growth rate of Liquid Biopsy Market.
Among the Circulating Biomarker, Ct- DNA is the most used biomarker for the diagnosis in pre and post cancerous stage, as it provides more comprehensive overview of the tumor genomic status. Ongoing research and clinical trials suggest that exosomes and nucleosomes, will provide more efficient diagnostic results and hence market will be growing in the forecast period.
In the forecast period, continuous research and development by private manufacturers, government organizations and designated government labs along with growing number of clinical trials in liquid biopsy is anticipated to provide momentum to the market growth. However, generation of revenue from the liquid biopsy is dependent upon the interest of third party payers, hindering the market growth.
Scope of the Report
Global Liquid Biopsy Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)
Liquid Biopsy Market: Size, Growth, Forecast
Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
Analysis By Product Type: Reagents, Instruments
Regional Liquid Biopsy Markets - North America, Europe, APAC, ROW (Actual Period: 2017-2018, Forecast Period: 2019-2024)
Liquid Biopsy Market: Size, Growth, Forecast
Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
Analysis By Product Type: Reagents, Instruments
Country Analysis U.S., Germany, France, Japan (Actual Period: 2017-2018, Forecast Period: 2019-2024)
Liquid Biopsy Market: Size, Growth, Forecast
Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
Analysis By Product Type: Reagents, Instruments
Company Analysis Roche Diagnostics, Thermo Fisher Scientific, Guardant Health, Qiagen.
Other Report Highlights
Competitive Landscape - Sales, Segments, Market Share, Business Strategies
Investment and Partnerships
Product Analysis
Market Dynamics Drivers and Restraints.
Market Trends
Porter Five Forces Analysis.
SWOT Analysis.
